Literature DB >> 8244483

Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life.

C P Thakur1, G P Sinha, V Sharma, A K Pandey, P K Sinha, D Barat.   

Abstract

Fifty children in the first decade of life, and suffering from multiple drug resistant kala-azar, confirmed by demonstration of amastigotes in aspirates of bone marrow or spleen were treated with amphotericin B in gradually increasing dosage to a total dose of 20 mg/kg. All patients had classical features of severe kala-azar, and had taken more than one course of antimony and pentamidine, and three patients had taken one additional course of ketoconazole besides many courses of antimony and pentamidine. The clinical response started just after first infusion in 8 patients, and the patients became afebrile. By 5th infusion, all looked better and 18 patients became afebrile. By 15th infusion all patients were afebrile and cheerful. Their spleens became smaller and body weights and total white cell counts increased. Forty eight patients had parasitological cure at the end of treatment, and only 2 patients required an additional 5 infusions for parasitological cure. All patients were ultimately cured. No one relapsed within six months of follow up. All patients had shivering, rigor and rise of temperature on the day of infusion, which could be minimized with prior administration of low dose of hydrocortisone, but could not be eliminated. Eighteen patients had loose motions during treatment, while 14 patients had decrease in appetite which improved quickly when the treatment was over. Fourteen patients had transient rise of blood urea, in six patients serum creatinine also increased and 16 patients had a minor fall in serum potassium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244483     DOI: 10.1007/bf02860503

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  Imported mucocutaneous leishmaniasis in New York City. Report of a patient treated with amphotericin B.

Authors:  C Singer; D Armstrong; T C Jones; R H Spiro
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

2.  TREATMENT OF KALA-AZAR WITH AMPHOTERICIN B.

Authors:  A PRATA
Journal:  Trans R Soc Trop Med Hyg       Date:  1963-07       Impact factor: 2.184

3.  Treatment of mucocutaneous (American) leishmaniasis with amphotericin B: report of 70 cases.

Authors:  S A Sampaio; R M Castro; N L Dillon; J E Martins
Journal:  Int J Dermatol       Date:  1971 Jul-Sep       Impact factor: 2.736

4.  Clinical profile of cases of kala-azar in Bihar.

Authors:  B K Aikat; S Sahaya; A G Pathania; P K Bhattacharya; N Desai; L S Prasad; S Mishra; S Jain
Journal:  Indian J Med Res       Date:  1979-10       Impact factor: 2.375

5.  Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol.

Authors:  C N Chunge; G Gachihi; R Muigai; K Wasunna; J R Rashid; J D Chulay; G Anabwani; C N Oster; A D Bryceson
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

6.  Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.

Authors:  C P Thakur; M Kumar; P Kumar; B N Mishra; A K Pandey
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

7.  Comparison of regimens of treatment with sodium stibogluconate in kala-azar.

Authors:  C P Thakur; M Kumar; S K Singh; D Sharma; U S Prasad; R S Singh; P S Dhawan; V Achari
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-24

8.  Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study.

Authors:  C P Thakur; M Kumar; A K Pandey
Journal:  Am J Trop Med Hyg       Date:  1991-10       Impact factor: 2.345

9.  Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys.

Authors:  J D Berman; W L Hanson; W L Chapman; C R Alving; G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

10.  An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.

Authors:  J D Berman; D J Wyler
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

  10 in total
  2 in total

1.  Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison.

Authors:  C P Thakur; G P Sinha; A K Pandey; D Barat; R K Singh
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

2.  Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.

Authors:  Caspar J Hodiamont; Piet A Kager; Aldert Bart; Henry J C de Vries; Pieter P A M van Thiel; Tjalling Leenstra; Peter J de Vries; Michèle van Vugt; Martin P Grobusch; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.